Efficacy of Statin Therapy in Pulmonary Arterial Hypertension: A Systematic Review and Meta-Analysis
Open accessThe DOI matches its Crossref record; 51 of the 52 references it cites were found in a registry or an index.
Abstract
Since the evidence regarding statin therapy in PAH has not been conclusive, we assessed the impact of statin therapy in PAH through a systematic review and meta-analysis of available studies. We searched selected databases up to August 1, 2015 to identify the studies investigating the effect of statin administration on PAH. Meta-analysis was performed using either a fixed-effects or random-effect model according to I2 statistic. Meta-analysis of 8 studies with 665 patients did not suggest any significant improvement in 6-min walking distance (6MWD) by statin therapy (weighed mean difference [WMD]: −6.08 m, 95% confidence interval [CI]: −25.66, 13.50, p = 0.543; Q = 8.41, I 2 = 28.64%). Likewise, none of the other indices including pulmonary arterial pressure (WMD: −0.97 mmHg, 95%CI: −4.39, 2.44, p = 0.577; Q = 14.64, I 2 = 79.51%), right atrial pressure (WMD: 1.01 mmHg, 95%CI: −0.93, 2.96, p = 0.307; Q = 44.88, I 2 = 95.54%), cardiac index (WMD: 0.05 L/min/m 2, 95%CI: −0.05, 0.15, p = 0.323; Q = 3.82, I 2 = 21.42%), and pulmonary vascular resistance (WMD: −1.42 dyn*s/cm 5, 95%CI: −72.11, 69.27, p = 0.969; Q = 0.69, I 2 = 0%) was significantly altered by statin therapy. In conclusion, the results of the meta-analysis did not show a statistically significant effect of statin therapy in the improvement of 6MWD, pulmonary arterial pressure, right atrial pressure, cardiac index and pulmonary vascular resistance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
(2009) · PubMed Central · Cited by 44,859
Duval, S., & Tweedie, R. (2000) · Biometrics · doi:10.1111/j.0006-341x.2000.00455.x · Cited by 14,099
Wan, X., Wang, W., Liu, J., & Tong, T. (2014) · BMC Medical Research Methodology · doi:10.1186/1471-2288-14-135 · Cited by 11,735 · cited 1×
“If the outcome measures were reported in median and range or 95% CI, mean and standard SD values were estimated using the method described by Wan et al.14.”
Method2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
Galiè, N., Humbert, M., Vachiery, J.-L., Gibbs, S., Lang, I., Torbicki, A., Simonneau, G., Peacock, A., Vonk Noordegraaf, A., Beghetti, M., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehv317 · Cited by 6,931
Self-citation(2000) · Queen Mary Research Online (Queen Mary University of London) · Cited by 1,795
Simvastatin Inhibits Cigarette Smoking–induced Emphysema and Pulmonary Hypertension in Rat Lungs
Lee, J.-H., Lee, D.-S., Kim, E.-K., Choe, K.-H., Oh, Y.-M., Shim, T.-S., Kim, S.-E., Lee, Y.-S., & Lee, S.-D. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200501-041oc · Cited by 257
Pharmacologic Therapy for Pulmonary Arterial Hypertension in Adults
Taichman, D. B., Ornelas, J., Chung, L., Klinger, J. R., Lewis, S., Mandel, J., Palevsky, H. I., Rich, S., Sood, N., Rosenzweig, E. B., et al. (2014) · Chest · doi:10.1378/chest.14-0793 · Cited by 256
Nishimura, T., Vaszar, L. T., Faul, J. L., Zhao, G., Berry, G. J., Shi, L., Qiu, D., Benson, G., Pearl, R. G., & Kao, P. N. (2003) · Circulation · doi:10.1161/01.cir.0000087592.47401.37 · Cited by 251
Lipid and Blood Pressure Meta-analysis Collaboration (LBPMC) Group, Banach, M., Serban, C., Sahebkar, A., Mikhailidis, D. P., Ursoniu, S., Ray, K. K., Rysz, J., Toth, P. P., Muntner, P., et al. (2015) · BMC Medicine · doi:10.1186/s12916-015-0459-4 · Cited by 217
Self-citationPulmonary arterial hypertension: the burden of disease and impact on quality of life
Delcroix, M., & Howard, L. (2015) · European Respiratory Review · doi:10.1183/16000617.0063-2015 · Cited by 186
Serban, C., Sahebkar, A., Ursoniu, S., Mikhailidis, D. P., Rizzo, M., Lip, G. Y. H., Kees Hovingh, G., Kastelein, J. J. P., Kalinowski, L., Rysz, J., et al. (2015) · Scientific Reports · doi:10.1038/srep09902 · Cited by 185
Self-citationStatin Use Reduces Decline in Lung Function: VA Normative Aging Study
Alexeeff, S. E., Litonjua, A. A., Sparrow, D., Vokonas, P. S., & Schwartz, J. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200705-656oc · Cited by 183
Sahebkar, A., Serban, C., Ursoniu, S., Mikhailidis, D. P., Undas, A., Lip, G. Y. H., Bittner, V., Ray, K. K., Watts, G. F., Hovingh, G. K., et al. (2016) · Thrombosis and Haemostasis · doi:10.1160/th15-08-0620 · Cited by 180
Self-citationSahebkar, A., Kotani, K., Serban, C., Ursoniu, S., Mikhailidis, D. P., Jones, S. R., Ray, K. K., Blaha, M. J., Rysz, J., Toth, P. P., et al. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.05.022 · Cited by 178
Self-citationAttenuation of chronic hypoxic pulmonary hypertension by simvastatin
Girgis, R. E., Li, D., Zhan, X., Garcia, J. G. N., Tuder, R. M., Hassoun, P. M., & Johns, R. A. (2003) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01097.2002 · Cited by 158
Mikhailidis, D., Undas, A., Lip, G., Muntner, P., Bittner, V., Ray, K., Watts, G., Hovingh, G. K., Rysz, J., Kastelein, J., et al. (2015) · Thrombosis and Haemostasis · doi:10.1160/th14-11-0937 · Cited by 156
Self-citationBlamoun, A. I., Batty, G. N., DeBari, V. A., Rashid, A. O., Sheikh, M., & Khan, M. A. (2008) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2008.01731.x · Cited by 144
Randomized Clinical Trial of Aspirin and Simvastatin for Pulmonary Arterial Hypertension: ASA-STAT
Kawut, S. M., Bagiella, E., Lederer, D. J., Shimbo, D., Horn, E. M., Roberts, K. E., Hill, N. S., Barr, R. G., Rosenzweig, E. B., Post, W., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.015693 · Cited by 139
Simvastatin as a Treatment for Pulmonary Hypertension Trial
Wilkins, M. R., Ali, O., Bradlow, W. M., Wharton, J., Taegtmeyer, A., Rhodes, C. J., Ghofrani, H. A., Howard, L., Nihoyannopoulos, P., Mohiaddin, R. H., et al. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2009111-699oc · Cited by 134
Statin Protects Endothelial Nitric Oxide Synthase Activity in Hypoxia-Induced Pulmonary Hypertension
Murata, T., Kinoshita, K., Hori, M., Kuwahara, M., Tsubone, H., Karaki, H., & Ozaki, H. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000186184.33537.48 · Cited by 123
Simvastatin Treatment of Pulmonary Hypertension*
Kao, P. N. (2005) · CHEST Journal · doi:10.1378/chest.127.4.1446 · Cited by 119
Regression of chronic hypoxic pulmonary hypertension by simvastatin
Girgis, R. E., Mozammel, S., Champion, H. C., Li, D., Peng, X., Shimoda, L. A., Tuder, R. M., Johns, R. A., & Hassoun, P. M. (2007) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00411.2006 · Cited by 111
Lee, T.-M., Chen, C.-C., Shen, H.-N., & Chang, N.-C. (2009) · Clinical Science · doi:10.1042/cs20080241 · Cited by 104
Wright, J. L., Zhou, S., Preobrazhenska, O., Marshall, C., Sin, D. D., Laher, I., Golbidi, S., & Churg, A. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201003-0399oc · Cited by 100
McMurtry, M. S., Bonnet, S., Michelakis, E. D., Bonnet, S. B., Haromy, A., & Archer, S. L. (2007) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00310.2006 · Cited by 78
Prognostic Significance of Biomarkers in Pulmonary Arterial Hypertension
Al‐Naamani, N., Palevsky, H. I., Lederer, D. J., Horn, E. M., Mathai, S. C., Roberts, K. E., Tracy, R. P., Hassoun, P. M., Girgis, R. E., Shimbo, D., et al. (2015) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201508-543oc · Cited by 69
Atorvastatin in Pulmonary Arterial Hypertension (APATH) study
Zeng, W., Xiong, C., Zhao, L., Shan, G., Liu, Z., Xue, F., Gu, Q., Ni, X., Zhao, Z., Cheng, X.-S., et al. (2012) · European Respiratory Journal · doi:10.1183/09031936.00149011 · Cited by 65
Sahebkar, A., Șerban, M.-C., Mikhailidis, D. P., Toth, P. P., Muntner, P., Ursoniu, S., Mosterou, S., Glasser, S. P., Martin, S. S., Jones, S. R., et al. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.12.001 · Cited by 65
Self-citationGiannakoulas, G. A., Mouratoglou, S., Gatzoulis, M. Α., & Karvounis, H. I. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.04.156 · Cited by 62
Șerban, M.-C., Sahebkar, A., Ursoniu, S., Mikhailidis, D. P., Rizzo, M., Lip, G. Y. H., Hovingh, G. K., Kastelein, J. J. P., Kalinowski, L., Rysz, J., et al. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.04.962 · Cited by 54
Self-citationSun, X., & Ku, D. D. (2008) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01112.2007 · Cited by 52
Simvastatin and sildenafil combine to attenuate pulmonary hypertension
Zhao, L., Sebkhi, A., Ali, O., Wójciak‐Stothard, B., Mamanova, L., Yang, Q., Wharton, J., & Wilkins, M. R. (2009) · European Respiratory Journal · doi:10.1183/09031936.00143508 · Cited by 51
Parikh, R. V., Scherzer, R., Nitta, E. M., Leone, A. M., Hur, S., Mistry, V., MacGregor, J. S., Martin, J. N., Deeks, S. G., Ganz, P., et al. (2014) · AIDS · doi:10.1097/qad.0000000000000124 · Cited by 45
EXPERIMENTAL & CLINICAL CARDIOLOGY
Haider, S., & Fernández‐Ortíz, A. (2014) · Cited by 45
Diagnostic and prognostic role of biomarkers for pulmonary hypertension in interstitial lung disease
Andersen, C. U., Mellemkjær, S., Nielsen‐Kudsk, J. E., Bendstrup, E. M., Simonsen, U., & Hilberg, O. (2012) · Respiratory Medicine · doi:10.1016/j.rmed.2012.09.003 · Cited by 43
Moosavi, S. A. J., Raji, H., Faghankhani, M., Yazdani, R., & Esmaeili, M. (2013) · Iranian Red Crescent Medical Journal · doi:10.5812/ircmj.8267 · Cited by 38
Barreto, A. C., Maeda, N. Y., Soares, R. P. S., Cícero, C., & Lopes, A. A. (2008) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2008000800003 · Cited by 33
Statin Therapy is Associated with Decreased Pulmonary Vascular Pressures in Severe COPD
Reed, R. M., Iacono, A. T., DeFilippis, A. P., Jones, S. R., Eberlein, M. H., Lechtzin, N., & Girgis, R. E. (2011) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.3109/15412555.2011.558545 · Cited by 33
Barnes, T. C., GLIDDON, A. E., Doré, C. J., Maddison, P. J., Moots, R. J., & the QUINs Trial Study Group (2012) · Lara D. Veeken · doi:10.1093/rheumatology/kes068 · Cited by 27
Lopes, A. A., Barreto, A. C., Maeda, N. Y., Cícero, C., Soares, R. P. S., Bydlowski, S. P., & Rich, S. (2011) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2011007500149 · Cited by 26
Matsuo, S., Saiki, Y., Adachi, O., Kawamoto, S., Fukushige, S., Horii, A., & Saiki, Y. (2014) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2014.10.030 · Cited by 25
Liu, H., Qi, X.-W., Ma, L.-L., Yao, D.-K., & Wang, L. (2013) · Europe PMC (PubMed Central) · Cited by 21
Carlin, C. M., Celnik, D. F., Pak, O., Wadsworth, R. M., Peacock, A. J., & Welsh, D. (2012) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2011-0411oc · Cited by 18
Holzhauser, L., Hovnanians, N., Eshtehardi, P., Mojadidi, M. K., Deng, Y., Goodman‐Meza, D., Msaouel, P., Ko, Y.-A., & Zolty, R. (2017) · Heart and Vessels · doi:10.1007/s00380-017-0957-8 · Cited by 15
Existing Drugs and Agents Under Investigation for Pulmonary Arterial Hypertension
Sharma, M., Pinnamaneni, S., Aronow, W. S., Jozwik, B., & Frishman, W. H. (2014) · Cardiology in Review · doi:10.1097/crd.0000000000000035 · Cited by 14
Krishna, R. K., Issa, O., Saha, D., Macedo, F., Correal, B., & Santana, O. (2014) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2014.08.006 · Cited by 11
Kato, F., Tanabe, N., Urushibara, T., Kasai, H., Takeuchi, T., Sekine, A., Suda, R., Nishimura, R., Jujo, T., Sugiura, T., et al. (2014) · Circulation Journal · doi:10.1253/circj.cj-13-1535 · Cited by 10
Toward Precision Medicine in Pulmonary Arterial Hypertension
Austin, E. D., & Loyd, J. E. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201508-1607ed · Cited by 9
Sinha, N., Devabhaktuni, S., Kadambi, A., McClung, J. A., Aronow, W. S., & Lehrman, S. G. (2014) · Archives of Medical Science · doi:10.5114/aoms.2014.44860 · Cited by 8
Statins for Treatment of Pulmonary Hypertension
Faul, J. L., Kao, P. N., Nishimura, T., Sung, A. W., Hu, H., & Pearl, R. G. (2008) · Humana Press eBooks · doi:10.1007/978-1-60327-075-5_15 · Cited by 1
Research works printed but not linked: 2
- Galiè, N. et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J 37, 67–119 (2016). · DOI · Paper page
- Faul, J. et al. In Pulmonary Hypertension Contemporary Cardiology™ (eds NicholasS Hill & HarrisonW Farber ) Ch. 15, 321–336 (Humana Press, 2008).
Cited by
Xu, Z., Henderson, R. D., David, M., & McCombe, P. (2016) · PLoS ONE · doi:10.1371/journal.pone.0164625 · Cited by 130
Wang, D., Uhrín, P., Mocan, A., Waltenberger, B., Breuss, J. M., Tewari, D., Mihaly‐Bison, J., Huminiecki, Ł., Starzyński, R. R., Tzvetkov, N. T., et al. (2018) · Biotechnology Advances · doi:10.1016/j.biotechadv.2018.04.006 · Cited by 116
Haber, N., Smith, E. R., Moscoe, E., Andrews, K., Audy, R., Bell, W., Brennan, A. T., Breskin, A., Kane, J. C., Karra, M., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0196346 · Cited by 97
“An example in the UK [3] highlights the dangers of weak and poorly-reported evidence: An estimated 200,000 patients temporarily ceased taking statins–drugs with strong evidence for efficacy and safety for treating hypertension [4, 5]–after press outlets reported on two studies suggesting that the medication was associ…”
BackgroundNeurofilament light chain as a biological marker for multiple sclerosis: a meta-analysis study
Cai, L., & Huang, J. (2018) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s173280 · Cited by 76
Interplay of Low-Density Lipoprotein Receptors, LRPs, and Lipoproteins in Pulmonary Hypertension
Calvier, L., Herz, J., & Hansmann, G. (2022) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2021.09.011 · Cited by 84
“However, recent published clinical trials and systematic reviews assessing the potential of statins in PH patients are controversial (48,50,144,149) and statins as an effective treatment in PH is still under debate.”
BackgroundResultInfluential
Metadata
- Authors
- Rysz-Górzynska, M., Gluba-Brzózka, A., Sahebkar, A., Serban, M.-C., Mikhailidis, D. P., Ursoniu, S., Toth, P. P., Bittner, V., Watts, G. F., Lip, G. Y. H., Rysz, J., Catapano, A. L., & Banach, M.
- Affiliations
- Medical University of Lodz (PL)
- Mashhad University of Medical Sciences (IR)
- The Royal Free Hospital (GB)
- Victor Babeș University of Medicine and Pharmacy Timișoara (RO)
- Johns Hopkins Medicine (US)
- University of Alabama at Birmingham (US)
- The University of Western Australia (AU)
- Birmingham City Hospital (GB)
- University of Milan (IT)
- Corresponding author
- Banach, Maciej
- ORCID
- Venue
- Scientific Reports
- Published
- 2016-07-22
- Volume
- 6
- Issue
- 1
- Pages
- 30060-30060
- ISSN
- 2045-2322 (ISSN-L)
- PMC
- PMC4957081
- OpenAlex
- W2495160769
- Cited by
- 33
- References
- 52
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 1 · 2023: 1 · 2022: 2 · 2021: 3 · 2020: 1 · 2019: 6 · 2018: 4 · 2017: 6 · 2016: 2
- FWCI
- 1.04
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Scientific Reports (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- UWA Profiles and Research Repository (UWA) (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) (submittedVersion, other-oa)
- Funders
- Uniwersytet Łódzki (REGPOT-2012-2013-1)
- FP7 Research Potential of Convergence Regions (REGPOT-2012-2013-1)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Pulmonary Hypertension Research and Treatments
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Keywords
- statin therapy, pulmonary arterial hypertension, 6-minute walk distance, pulmonary vascular resistance, right atrial pressure, cardiac index, pulmonary artery pressure, exercise capacity
- MeSH terms
- Female, Humans, Hypertension, Pulmonary, Male, Vascular Resistance, Treatment Outcome, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Atrial Pressure, Arterial Pressure
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.